Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label single-arm study of LTC004 in metastatic colorectal cancer after failure of third-line or later standard therapy
CTR20241454Phase 2Active
- Sponsor
- Beijing Zhidao Biotechnology
- Start
- Apr 2024
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of LTC004 in colorectal cancer (CRC), sponsored by Beijing Zhidao Biotechnology. Started Apr 2024; status: active.
02
Drugs
LTC004
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on CTR20241454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241454.